Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02243397 · ClinicalTrials.gov registry record
Molecular and Cellular Analysis of Breast Cancer
A clinical trial of Breast - Female and Breast - Male, sponsored by Stanford University.
- Completed
- Registry status
- 145
- Enrollment target
- 1
- Study location
NCT02243397: Completed study of Breast - Female and Breast - Male, sponsored by Stanford University.
NCT02243397 is a study of Breast - Female and Breast - Male that has completed, run by Stanford University. The registered enrollment target is 145 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02243397, a study of Breast - Female and Breast - Male, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond to various treatments.
Primary Outcome
We will be measuring levels of GM-CSF (Granulocyte-macrophayge colony stimulating factor) from the plasma of the patient before during and after the irradiation treatment to study if there is any increase in the GM-CSF production
Conditions Studied
Study Locations (1)
California
- Stanford University Cancer Institute - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2014-09-10 |
| Est. Completion | 2021-04-19 |
What the finished NCT02243397 record still lists
NCT02243397 is an observational study that tracks outcomes without assigning an intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Breast - Female appearing as the primary indexed condition, and to 0 interventions.
NCT02243397 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02243397 about?
NCT02243397 is a clinical study titled "Molecular and Cellular Analysis of Breast Cancer". The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond...
What is the current status of trial NCT02243397?
This trial is currently completed. The enrollment target is 145 participants. The study started on 2014-09-10. Estimated completion is 2021-04-19.
What conditions does trial NCT02243397 study?
This clinical trial studies the following conditions: Breast - Female, Breast - Male.
Who is sponsoring clinical trial NCT02243397?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02243397 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast - Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI